Home › Myasthenia Gravis
Pag-aaral pangklinika para sa Myasthenia Gravis na nagre-recruit sa U.S.
45 pag-aaral para sa Myasthenia Gravis ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Tampa, FL12 pag-aaral
- Houston, TX11 pag-aaral
- Durham, NC10 pag-aaral
- Boca Raton, FL10 pag-aaral
- Columbus, OH8 pag-aaral
- Milwaukee, WI7 pag-aaral
- St. Louis, MO7 pag-aaral
- Miami, FL7 pag-aaral
- New York City, NY7 pag-aaral
- Dallas, TX6 pag-aaral
- Columbia, MO6 pag-aaral
- Philadelphia, PA6 pag-aaral
- Jacksonville, FL6 pag-aaral
- Orange, CA6 pag-aaral
- Washington, DC6 pag-aaral
- Boston, MA6 pag-aaral
- Chattanooga, TN6 pag-aaral
- Austin, TX6 pag-aaral
- Charleston, SC6 pag-aaral
- Kansas City, KS6 pag-aaral
- San Francisco, CA6 pag-aaral
- Portland, OR6 pag-aaral
- Detroit, MI6 pag-aaral
- Scottsdale, AZ5 pag-aaral
- Lexington, KY5 pag-aaral
- Port Charlotte, FL5 pag-aaral
- Cincinnati, OH5 pag-aaral
- Aurora, CO5 pag-aaral
- New Haven, CT4 pag-aaral
- Augusta, GA4 pag-aaral
- Los Angeles, CA4 pag-aaral
- Mountain View, CA4 pag-aaral
- Amherst, NY4 pag-aaral
- Chicago, IL4 pag-aaral
- Knoxville, TN3 pag-aaral
- Clearwater, FL3 pag-aaral
- Lansing, MI3 pag-aaral
- Brockton, MA3 pag-aaral
- Indianapolis, IN3 pag-aaral
- Phoenix, AZ3 pag-aaral
Ayos sa estado
- Arizona7 pag-aaral
- California20 pag-aaral
- Colorado8 pag-aaral
- Connecticut6 pag-aaral
- District of Columbia6 pag-aaral
- Florida22 pag-aaral
- Georgia4 pag-aaral
- Illinois12 pag-aaral
- Indiana3 pag-aaral
- Kansas7 pag-aaral
- Kentucky6 pag-aaral
- Massachusetts11 pag-aaral
- Michigan12 pag-aaral
- Minnesota3 pag-aaral
- Missouri7 pag-aaral
- Nevada3 pag-aaral
- New Jersey3 pag-aaral
- New York13 pag-aaral
- North Carolina14 pag-aaral
- Ohio13 pag-aaral
- Oregon8 pag-aaral
- Pennsylvania6 pag-aaral
- South Carolina7 pag-aaral
- Tennessee10 pag-aaral
- Texas18 pag-aaral
- Virginia3 pag-aaral
- Wisconsin7 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Feasibility of Remote Monitoring of Patients With Myasthenia Gravis
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07787247A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07463521Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
Nagre-recruitPhase 3
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07217587A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07647510ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07673627ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07294170A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07465289ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07284420A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07673744Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06463587A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07501702A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06680037A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
Nagre-recruitPhase 2
Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06987539Zilucoplan for Severe gMG Exacerbations
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07215949Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT06414954AXIS MG Patient Registry
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07761026A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
Nagre-recruitPhase 1
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT07304154RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
Nagre-recruitPhase 1/2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Ago 13, 2026 · NCT06359041Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 64 · Kababaihan · Na-update Ago 11, 2026 · NCT06940323MuSK Myasthenia 1000 Study
Nagre-recruitObservasyonal na pag-aaral
Edad 7 hanggang 99 · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06259071Study of Aritinercept in Patients With Generalized Myasthenia Gravis
Nagre-recruitPhase 1/2
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT07596901A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
Nagre-recruitPhase 2/3
Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT05265273Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Nagre-recruitPhase 3
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT07039916KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Nagre-recruitPhase 2/3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT06193889A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT04951622Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.